Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
HealthTree Research: HealthTree Active Research Projects
You can find all open HealthTree research projects in HealthTree Cure Hub
Bispecific Antibody Study
The multiple myeloma medical community is now able to provide bispecific antibody therapy to patients. This is a major study initiative that will be open to patients receiving bispecific antibodies, and will be open for enrollment for a minimum of 3 years. The study consists of 8 sections designed to gather information about various aspects of the patient experience with bispecific antibodies, ranging from initial awareness to quality of life after at least four months of treatment.
Because there are now three FDA approved bispecific antibodies with more coming in clinical development, this is critical information doctors need to know to correctly prescribe this therapy to myeloma patients. Learn More
Defining Your Cure: Mapping the Patient Vision for Life After Myeloma
This survey gives multiple myeloma patients a direct voice in defining what a true "cure" means by balancing strict clinical guidelines with real-world quality of life, treatment trade-offs, and personal peace of mind. Help us ensure the medical community's standards align with the real-world patient preferences.What would a true “cure” for multiple myeloma mean to you? This HealthTree Foundation study is being conducted in collaboration with multiple myeloma experts across leading cancer centers.
Living Through CAR T: A Patient Experience Survey and Real World Study
Share your experience with CAR T-cell therapy and help researchers better understand what matters most before, during, and after treatment.
This HealthTree Foundation study, led in collaboration with myeloma experts from Huntsman Cancer Institute, Sarah Cannon Research Institute, Moffitt Cancer Center, and Mayo Clinic, explores treatment decisions, side effects, quality of life, caregiver support, and follow-up care.
Your perspective can help us make a difference in education, care, and support for future patients.
Moving Without Fear: Exercise Habits and Bone Safety in Multiple Myeloma
Your experience can help improve our understanding of physical activity and bone health in people with multiple myeloma. Dr. Jens Hillengass at Roswell Park Comprehensive Cancer Center is conducting a survey to learn how exercise habits, personal experiences, and guidance from healthcare teams influence physical activity and decisions about exercising safely.
By sharing your experience, you can help researchers better understand what supports patients in staying active while protecting their bone health.
Your Induction Experience: Triplets, Quads, and Stem Cell Transplant
Share your perspective on quadruplet therapy and help researchers understand what matters most to patients when making myeloma treatment decisions. This survey, led by Dr. Gurbakhash Kaur at the Icahn School of Medicine at Mount Sinai, explores how patients weigh the potential benefits and risks of four-drug treatment regimens.
Access, Treatment, and Trust: Understanding Disparities in Myeloma Patient Experiences
Help Dr. Craig Cole and Dr. Jeff Zonder at Karmanos Cancer Institute, understand your experiences with multiple myeloma treatment and care, with particular attention to any differences you may have encountered based on race or ethnicity. Your responses will contribute to research efforts aimed at identifying and addressing disparities in myeloma care.
Beyond the Clinic Appointment: Empowering Black Patients to Consider Novel Immunotherapies in Myeloma
Learn more about advanced myeloma treatments and share how education may influence your treatment decisions. This study, led by Dr. Joselle M. Cook at Mayo Clinic, explores how a physician-led virtual education session affects Black and African American patients’ knowledge, perceived barriers, and willingness to consider bispecific antibody therapy.
Improving AML Care Together: Patient & Caregiver Perspectives
Share your experience with AML, from diagnosis and treatment to relapse, recovery, and ongoing care.
This study, led by Dr. Andrew Jonas at UC Davis Comprehensive Cancer Center and HealthTree Foundation, explores the experiences and support needs of people with AML and their caregivers. Your perspective can help us identify where education, resources, and support could better meet the needs of patients and families throughout their AML journey.
CLL Treatment Experience Survey: Patient Insights
Share your experience with CLL treatment and help us better understand what matters most to patients when making treatment decisions. This brief survey explores treatment experiences, goals, priorities, and how CLL affects quality of life. Your perspective can help us improve patient education, resources, and advocacy where it really matters.